TMCI (STOCKS)
Treace Medical Concepts, Inc. Common Stock
$1.980000
+0.170000 (+9.39%)
Prev close: $1.810000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John T. Treace
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $129.83M
- Employees
- 477
- P/E (TTM)
- -1.94
- P/B (TTM)
- 1.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
5
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.15 | $-0.15 | +0.0030 | +1.96% |
|
Sep 2025 (Q3)
|
$-0.26 | $-0.29 | +0.0256 | +8.96% |
|
Jun 2025 (Q2)
|
$-0.28 | $-0.29 | +0.0141 | +4.79% |
|
Mar 2025 (Q1)
|
$-0.25 | $-0.31 | +0.0575 | +18.70% |
Financial Statements
| Revenues | $212.69M |
| Benefits Costs and Expenses | $271.69M |
| Cost Of Revenue | $42.94M |
| Costs And Expenses | $271.69M |
| Gross Profit | $169.75M |
| Operating Expenses | $223.91M |
| Research and Development | $20.28M |
| Other Operating Expenses | $203.62M |
| Operating Income/Loss | -$54.15M |
| Income/Loss From Continuing Operations After Tax | -$59.00M |
| Income/Loss From Continuing Operations Before Tax | -$59.00M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $5.32M |
| Net Income/Loss | -$59.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$59.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$59.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.93 |
| Diluted Earnings Per Share | -$0.93 |
| Basic Average Shares | 63,269,003 |
| Diluted Average Shares | 63,269,003 |
| Assets | $190.58M |
| Current Assets | $132.05M |
| Inventory | $36.03M |
| Other Current Assets | $96.02M |
| Noncurrent Assets | $58.53M |
| Fixed Assets | $29.75M |
| Intangible Assets | $7.13M |
| Other Non-current Assets | $21.65M |
| Liabilities | $103.25M |
| Current Liabilities | $30.64M |
| Accounts Payable | $6.73M |
| Wages | $6.33M |
| Other Current Liabilities | $17.58M |
| Noncurrent Liabilities | $72.61M |
| Long-term Debt | $55.58M |
| Other Non-current Liabilities | $17.03M |
| Equity | $87.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $87.33M |
| Liabilities And Equity | $190.58M |
| Net Cash Flow From Operating Activities | -$15.97M |
| Net Cash Flow From Operating Activities, Continuing | -$15.97M |
| Net Cash Flow From Investing Activities | $13.25M |
| Net Cash Flow From Investing Activities, Continuing | $13.25M |
| Net Cash Flow From Financing Activities | $2.08M |
| Net Cash Flow From Financing Activities, Continuing | $2.08M |
| Net Cash Flow | -$642.00K |
| Net Cash Flow, Continuing | -$642.00K |
| Comprehensive Income/Loss | -$59.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$59.03M |
| Other Comprehensive Income/Loss | -$25.00K |